Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study
Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study
复制标题
DOI:
10.1136/thoraxjnl-2020-215917
复制
发表时间:
2021-03-01
期刊:
影响因子:
10
通讯作者:
Suda, Takafumi
中科院分区:
文献类型:
--
作者:
Koyauchi, Takafumi;Suzuki, Yuzo;Suda, Takafumi
BackgroundThere is limited knowledge regarding the quality of dying and death (QODD) and end-of-life interventions in patients with interstitial lung disease (ILD). Hence, differences in QODD and end-of-life interventions between patients with ILD and those with lung cancer (LC) remain poorly understood.MethodsThe primary aim of this study was to explore the differences in QODD and end-of-life interventions among patients dying with ILD versus those dying with LC. We performed a mail survey to quantify the QODD of a bereaved family's perspective using the Good Death Inventory (GDI) score. Moreover, we examined the end-of-life interventions by medical chart review.ResultsOf 361 consecutive patients analysed for end-of-life interventions, 167 patients whose bereaved families completed questionnaires were analysed for QODD. Patients with ILD had lower GDI scores for QODD than those with LC (p=0.04), particularly in domains related to 'physical and psychological distress relief' and 'prognosis awareness and participation in decision making' (p=0.02, respectively). In end-of-life interventions, patients with ILD were less likely to receive specialised palliative care services (8.5% vs 54.3%; p